Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R First

Showing results (221-230 of 266) with videos related to

Pageof 27
Sort By:
Transplantation Proceedings|April 26, 2005
Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experienceE S Woodle, M Gupta, J F Buell, et al.
Transplantation Proceedings|February 1, 1993
Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantationJ W Alexander, C B Davies, M R First, et al.
Journal of the American Society of Nephrology : JASN|November 1, 1994
Safety and efficacy of recombinant human erythropoietin in correcting the anemia of patients with chronic renal allograft dysfunctionN Muirhead, D C Cattran, J Zaltzman, et al.
Transplantation|December 1, 1984
Proteinuria following transplantation. Correlation with histopathology and outcomeM R First, P N Vaidya, R K Maryniak, et al.
The Journal of Surgical Research|November 1, 1975
Comparison of goat ATLG and ASLG in human renal transplantsJ W Alexander, E J Smith, A J McAdams, et al.
Transplantation Proceedings|February 1, 1997
Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipientsM el-Ghoroury, S Hariharan, V R Peddi, et al.
Therapeutic Drug Monitoring|August 1, 1994
Variations in serum OKT3 concentration based upon age, sex, transplanted organ, treatment regimen, and anti-OKT3 antibody statusT J Schroeder, A T Michael, M R First, et al.
Transplantation Proceedings|September 2, 1998
Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence methodM R First, P Weiskittel, M Burton, et al.
Transplantation Proceedings|August 15, 2002
De novo breast cancer in renal transplant recipientsJoseph F Buell, M J Hanaway, J Trofe, et al.
Transplantation Proceedings|February 1, 1997
A multicenter report on the utilization of Banff grading in acute renal rejection. The 1995 Efficacy Endpoints ConferenceL W Gaber, L W Moore, A O Gaber, et al.
Pageof 27

Showing results (221-230 of 266) with videos related to

Sort By:
Pageof 27
Transplantation Proceedings|April 26, 2005
Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experienceE S Woodle, M Gupta, J F Buell, et al.
Transplantation Proceedings|February 1, 1993
Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantationJ W Alexander, C B Davies, M R First, et al.
Journal of the American Society of Nephrology : JASN|November 1, 1994
Safety and efficacy of recombinant human erythropoietin in correcting the anemia of patients with chronic renal allograft dysfunctionN Muirhead, D C Cattran, J Zaltzman, et al.
Transplantation|December 1, 1984
Proteinuria following transplantation. Correlation with histopathology and outcomeM R First, P N Vaidya, R K Maryniak, et al.
The Journal of Surgical Research|November 1, 1975
Comparison of goat ATLG and ASLG in human renal transplantsJ W Alexander, E J Smith, A J McAdams, et al.
Transplantation Proceedings|February 1, 1997
Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipientsM el-Ghoroury, S Hariharan, V R Peddi, et al.
Therapeutic Drug Monitoring|August 1, 1994
Variations in serum OKT3 concentration based upon age, sex, transplanted organ, treatment regimen, and anti-OKT3 antibody statusT J Schroeder, A T Michael, M R First, et al.
Transplantation Proceedings|September 2, 1998
Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence methodM R First, P Weiskittel, M Burton, et al.
Transplantation Proceedings|August 15, 2002
De novo breast cancer in renal transplant recipientsJoseph F Buell, M J Hanaway, J Trofe, et al.
Transplantation Proceedings|February 1, 1997
A multicenter report on the utilization of Banff grading in acute renal rejection. The 1995 Efficacy Endpoints ConferenceL W Gaber, L W Moore, A O Gaber, et al.
Pageof 27